STENTiT Resorbable Fibrillated Scaffold (RFS)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for STENTiT Resorbable Fibrillated Scaffold (RFS), covering 2025-07-09 to 2025-07-09. Get the full timeline:
Most recent: Clinical Trial Update: Initial Feasibility Study of the STENTiT Resorbable Fibrillated Scaffold (RFS). The RFS is Intended to Restore Lumen Patency and Blood Flow to Infrapopliteal Arteries. The RFS is a Fully Electrospun Tubular Device With a Fibrillated Microarchitecture and Designed for Transcatheter Delivery [NA]